Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
Status:
Not yet recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
This research study aims to learn more about the impact the hormone aldosterone on the heart.
Primary aldosteronism is a condition where the body's adrenal glands make too much of the
hormone aldosterone, which can cause high blood pressure and increase the risk of heart and
kidney disease. Treatment with medications that block aldosterone can reduce that risk. This
study is trying to learn whether treatment with a medication that blocks aldosterone can
improve heart function in people who make too much aldosterone.